China’s first national level medical high-tech industrial development zone was established in Taizhou, Jiangsu province, on 29 May.

This zone will specialise in the manufacture of five product categories: vaccines, new agents of chemical compound medicines, biomedicine, Chinese medicine and high-end medical equipment.

So far, the zone has attracted more than 40 medical research and development institutes including Hamuna Research Institute, Texas Medical Center from the US and China Pharmaceutical University. More than 100 pharmaceutical production and service enterprises have set up in the zone.